Wolowacz SE, Roskell NS, Maciver F, Beard SM, Robinson P, Plumb J. Cost-effectiveness of dabigatran etexilate for the primary prevention of venous thromboembolism in patients undergoing total hip or total knee replacement surgery. Poster presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece. [abstract] Value Health. 2008 Nov; 11(6):A404.
Wolowacz SE, Hess N, Brennan VK, Monz BU, Plumb JM. Cost-effectiveness of venous thromboembolism prophylaxis in total hip and knee replacement surgery: the evolving application of health economic modelling over 20 years. Curr Med Res Opin. 2008 Oct 1;24(10):2993-3006.
Brennan VK, Wolowacz SE. A systematic review of breast cancer utility weights. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 7, 2008. [abstract] Value Health. 2008 May; 11(3):A77.
Wolowacz SE, Cameron DA, Tate HC, Bagust A. Docetaxel in combination with doxorubicin and cyclophosphamide as adjuvant treatment for early node-positive breast cancer: a cost-effectiveness and cost-utility analysis. J Clin Oncol. 2008 Feb 20;26(6):925-33.
Javitt JC, Wolowacz SE, Roskell NS, Maciver F, Kelly S, Pleil AM, Zlateva GP. Cost-effectiveness of pegaptanib in age-related macular degeneration: the impact of differences between USA and UK health care systems. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A370.
Wolowacz SE, Roskell NS, Maciver F, Kelly S. Cost-utility analysis for pegaptanib in age-related macular degeneration in the UK: the impact of demographic and disease characteristics. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A370.
Wolowacz SE. The National Institute for Health and Clinical Excellence (NICE) Single Technology Appraisal (STA) process: an update on the first round of submissions. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006.
Sculpher M, Longson C, Wolowacz SE, Khan S. The new National Institute of Health And Clinical Excellence (NICE) Single Technology Appraisal (STA) process: experience from the first round of completed appraisals. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 28, 2006. Copenhagen, Denmark.
Sculpher M, Longson C, Wolowacz SE, Khan S. The new National Institute of Health And Clinical Excellence (NICE) Single Technology Appraisal (STA) process: experience from the first round of submissions. Poster presented at the 2006 ISPOR 11th Annual International Meeting; May 2006. Philadelphia, PA.
Longson C, Wolowacz SE, Sculpher MJ, Khan SB. The National Institute of Health and Clinical Excellence (NICE) Single Technology Appraisal (STA) process: an update on the first round of submission. Presented at the 2006 ISPOR 11th Annual International Meeting; May 2006. Philadelphia, PA.